Wednesday, February 02, 2022 5:21:57 PM
Think about that, the companies marketcap is $30ish million while going from 25 million shares to billions and decline from$0.85 to $0.035 and lower. All the dilution has propped the marketcap. Who makes up the marketcap? All the investors who have bought from $.85 to now. That money on volume went somewhere.
The company is bleeding money and counts on bad financing to keep up. They have raised over $20 million and are constantly out of cash. The guys who invested that capital are making money from everyone who buys because they sell.
If they were ramping revenue and even close to a blockbuster, the orbimeds would be pushing $50 million in to get product and distribution to scale.
Do you really think that the company has the capacity to handle scale?
I wish I was wrong but you can't trust the execution at this point imo.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM